https://genderreport.ca/the-swedish-u-turn-on-gender-transitioning/
In the group of 13–17-year-old natal females, the Swedish NBHW report states that the comorbidity is greatest. In this unprecedented cohort of teenaged girls seeking gender transition the following co-morbidities were found:
Update: May 5, 2021 The U-turn is official.
Sweden has officially ended the practice of prescribing puberty blockers and cross-sex hormones for minors under age 18. They have recognized the experimental nature of treating minors with puberty blockers and hormones and have established new protocols that deviate significantly from WPATH and the “professional associations” that the Canadian government and healthcare authorities are listening to. You can access the official documents and read more at the summary published by the Society for Evidence-based GenderIn the group of 13–17-year-old natal females, the Swedish NBHW report states that the comorbidity is greatest. In this unprecedented cohort of teenaged girls seeking gender transition the following co-morbidities were found:
- 32.4 percent anxiety disorder
- 28.9 percent some form of depressive disorder
- 19.4 percent ADHD
- 15.2 percent autism